How it works for universities
We help universities to…
Engage with industry teams from all sectors looking for a wide range of opportunities from early-stage to late-stage research, technologies, spin-outs and expertise for consultancy.
- Connect with industry teams in 6,000+ companies
- Proactively showcase opportunities to decision-makers
- Assess performance through analytics and metrics
How universities engage through IN-PART
Start new conversations through Connect
Have your research proactively matched to companies with aligned interests.
- A closed-loop platform accessible only to industry decision-makers
- A portal to sync disclosures with your website
A unique view on industry engagement
Evaluate and benchmark interest from industry
- A bespoke dashboard for your institute
- Real-time analytics and engagement metrics
- Qualitative feedback to inform decisions and funding applications
Respond to industrial requirements through Discover
A new route to engage with industry challenges and funding opportunities
- Weekly alerts with new industry campaigns
- Companies looking for a wide range of opportunities
- A simple submission process and progress tracking through an online dashboard
Create impact with us
A global gateway to new industry partners
Meaningful conversations with decision-makers
Accelerate the commercialisation of research
We help universities create impact
Matching research with industry on a level playing field globally.
Active Connect Technologies
Preventing Therapy-related Cardiomyopathy Associated with Neutrophil Infiltration
University of Virginia
Compositions and methods for treating and/or preventing therapy-related cardiomyopathy associated with neutrophil infiltration
Priming with Bispecific Antibody Armed Activated T Cells (BAT) Can Kill Resistant Pancreatic Cancer Cell Lines and Enhance Chemoresponsiveness
University of Virginia
BATs can kill chemo-resistant pancreatic cancer cells, and pre-treatment lowers the threshold for chemotherapy, improving survival
Target-specific Delivery of Therapeutic Agents for Post-MI Heart Failure
University of Virginia
Liposome‑bearing peptides targeting damaged heart tissue as ideal vehicles to focus the delivery of small molecule therapeutics
| Features & capabilities | ||
| Discover | Connect | |
| Basic | Premium | |
| Get started | Request demo | |
| Submit opportunities at your institute to campaigns from innovation-driven companies |  | |
| View and manage submissions from academics at your institute to Discover campaigns | | |
| Showcase your technology portfolio for matching and proactive dissemination to our industry network | | |
| Showcase a profile of your university or institute to our industry network | | |
| Generate standardised summaries of your opportunities with visuals, illustrations and graphics | | |
| Access your own public Technology Portal for use on internal websites | | |
| View and export performance analytics and industry engagement metrics through a customisable dashboard | | |
| A dedicated STEM-qualified account manager for on-demand support | | |
| Collaborative tools to review and manage technologies and commercialisation opportunities across your team | |
We work with
Universities
Companies
Testimonials
What our customers say
"IN-PART is the best platform we've ever worked with! We've been subscribed since the start of 2018, and have received a range of useful introductions and feedback for our technologies from relevant companies in Europe and beyond."
“The analytical tools in our University Dashboard and Impact Reports give us further insight on how our technologies are doing and the ability to assess whether we are presenting them in the right manner. Without IN-PART, we would not have the information to make such comparisons on our technologies..."
“IN-PART has been really useful in terms of networking and progressing our technology’s development. We are closer to market for specific applications of our technology because of the partnerships we have formed through IN-PART.”